Acceder

Publicaciones - HEMATOLOGÍA Y ONCOLOGÍA MÉDICA CLÍNICO-EXPERIMENTAL

Cargando...
Mussetti A, Bento L, Bastos-Oreiro M, Rius-Sansalvador B, Albo C, Bailen R, Barba P, Benzaquen A, Briones J, Caballero AC, Campos A, Espanol I, Ferra C, Lopez SG, Gonzalez Sierra PA, Guerra LM, Hernani R, Iacoboni G, Jimenez-Ubieto A, Kwon M, Corral LL, Lopez-Godino O, Munoz MCM, Martinez-Cibrian N, Gomez JM, Perez-Ortega L, Orti G, Ortiz-Maldonado V, Pascual MJ, Perera M, Perez A, Reguera JL, Sanchez JM, Sanz J, Torrent A, Yanez L, Varela R, Echechipia IC, Caballero D, Sureda A. Role of allogeneic hematopoietic cell transplant for relapsed/refractory aggressive B-cell lymphomas in the CART era. Bone Marrow Transplant. 2023 Jun;58(6):673-679. doi: 10.1038/s41409-023-01949-x. Epub 2023 Mar 14. Erratum In: Bone Marrow Transplant. 2023 Jun;58(6):738. doi: 10.1038/s41409-023-01967-9. PubMed PMID: 36918682.
AÑO: 2023; IF: 4.5
36918682
Cruz D, Rodriguez-Romanos R, Gonzalez-Bartulos M, Garcia-Cadenas I, de la Camara R, Heras I, Buno I, Santos N, Lloveras N, Velarde P, Tuset E, Martinez C, Gonzalez M, Sanz GF, Ferra C, Sampol A, Coll R, Perez-Simon JA, Lopez-Jimenez J, Jurado M, Gallardo D. LAG3 genotype of the donor and clinical outcome after allogeneic transplantation from HLA-identical sibling donors. Front Immunol. 2023 Jan 20;14:1066393. doi: 10.3389/fimmu.2023.1066393. eCollection 2023. PubMed PMID: 36742309; PubMed Central PMCID: PMC9897054.
AÑO: 2023; IF: 5.7
36742309
Megy K, Downes K, Morel-Kopp MC, Bastida JM, Brooks S, Bury L, Leinoe E, Gomez K, Morgan NV, Othman M, Ouwehand WH, Botero JP, Rivera J, Schulze H, Tregouet DA, Freson K. Corrigendum to GoldVariants, a resource for sharing rare genetic variants detected in bleeding, thrombotic, and platelet disorders: Communication from the ISTH SSC Subcommittee on Genomics in Thrombosis and Hemostasis [J Thromb Haemost. 2021 Oct;19(10):2612-2617]. J Thromb Haemost. 2023 Apr;21(4):1067. doi: 10.1016/j.jtha.2023.01.021. Epub 2023 Feb 1. No abstract available. PubMed PMID: 36737374; PubMed Central PMCID: PMC10501975.
AÑO: 2023; IF: 5.5
36737374
Zaragoza-Huesca D, Rodenas MC, Penas-Martinez J, Pardo-Sanchez I, Pena-Garcia J, Espin S, Ricote G, Nieto A, Garcia-Molina F, Vicente V, Lozano ML, Carmona-Bayonas A, Mulero V, Perez-Sanchez H, Martinez-Martinez I. Suramin, a drug for the treatment of trypanosomiasis, reduces the prothrombotic and metastatic phenotypes of colorectal cancer cells by inhibiting hepsin. Biomed Pharmacother. 2023 Dec;168:115814. doi: 10.1016/j.biopha.2023.115814. Epub 2023 Oct 31. PubMed PMID: 37918256.
AÑO: 2023; IF: 6.9
37918256
Guarnera L, Bravo-Perez C, Visconte V. Immunotherapy in Acute Myeloid Leukemia: A Literature Review of Emerging Strategies. Bioengineering (Basel). 2023 Oct 20;10(10):1228. doi: 10.3390/bioengineering10101228. PubMed PMID: 37892958; PubMed Central PMCID: PMC10604866.
AÑO: 2023; IF: 3.8
37892958
< AnteriorSiguiente >
IMIB-Arrixaca

Instituto de Investigación Sanitaria Acreditado

ISCII

HEMATOLOGÍA Y ONCOLOGÍA MÉDICA CLÍNICO-EXPERIMENTAL